Assessing the WHO 50% prevalence threshold in school-aged children as indication for treatment of urogenital schistosomiasis in adults in Central Nigeria

American Journal of Tropical Medicine and Hygiene

Volumn 88, Issue 3, 2013, Pages 441-445

  Evans, Darin S ^a   King, Jonathan D ^a   Eigege, Abel ^a   Umaru, John ^a   Adamani, William ^a   Alphonsus, Kal ^a   Sambo, Yohanna ^a   Miri, Emmanual S ^a   Goshit, Danjuma ^b   Ogah, Gladys ^c   Richards, Frank O ^a  

^a CARTER CENTER   (United States)

^b Plateau State Ministry of Health   (Nigeria)

^c Nasarawa Ministry of Health Nigeria   (Nigeria)

Author keywords

[No Author keywords available]

Indexed keywords

PRAZIQUANTEL; ANTHELMINTIC AGENT;

ADULT; ARTICLE; CHEMOPROPHYLAXIS; CHILD; CLINICAL DECISION MAKING; DISEASE CONTROL; DISEASE SEVERITY; ENDEMIC DISEASE; FEMALE; HEALTH PROGRAM; HEMATURIA; HUMAN; MAJOR CLINICAL STUDY; MALE; MORBIDITY; NIGERIA; PREDICTION; PRESCHOOL CHILD; PREVALENCE; RISK ASSESSMENT; SCHISTOSOMA HEMATOBIUM; SCHISTOSOMIASIS; SCHISTOSOMIASIS HAEMATOBIA; TREATMENT INDICATION; UROGENITAL SCHISTOSOMIASIS; WORLD HEALTH ORGANIZATION; AGING;

ADULT; AGING; ANTHELMINTICS; CHILD; FEMALE; HUMANS; MALE; NIGERIA; PRAZIQUANTEL; PREVALENCE; SCHISTOSOMIASIS HAEMATOBIA; WORLD HEALTH ORGANIZATION;

MLCS; MLOWN;

EID: 84877097043     PISSN: 00029637     EISSN: None     Source Type: Journal    
DOI: 10.4269/ajtmh.12-0511     Document Type: Article

References (20)

1. World Health Organization, 2006. Preventive Chemotherapy in Human Helminthiasis: Coordinated Use of Anthelminthic Drugs in Control Interventions: A Manual for Health Professionals and Programme Managers. Geneva, Switzerland: World Health Organization.
2. Savioli L, Gabrielli AF, Montresor A, Chitsulo L, Engels D, 2009. Schistosomiasis control in Africa: 8 years after World Health Assembly Resolution 54.19. Parasitoloty 136: 1677-1681.
3. Gutman J, Fagbemi A., Alphonsus K, Eigege A, Miri ES, Richards FO Jr, 2008. Missed treatment opportunities for schistosomiasis mansoni, in an active programme for the treatment of urinary schistosomiasis in Plateau and Nasarawa states, Nigeria. Ann Trop Med Parasitol 102: 335-346. (Pubitemid 351881276)
4. King JD, Eigege A, Richards FO, Jip N, Umaru J, Deming M, Miri E, McFarland D, Emerson P, 2009. Integrating NTD mapping protocols: can surveys for trachoma and urinary schistosomiasis be done simultaneously? Am J Trop Med Hyg 81: 793-798.
5. King CH, Sturrock RF, Kariuki HC, Hamburger J, 2006. Transmission control for schistosomiasis - why it matters now. Trends Parasitol 22: 575-582. (Pubitemid 44716725)
6. King CH, Dickman K, Tisch DJ, 2005. Reassessment of the cost of chronic helminthic infection: a meta-analysis of disability-related outcomes in endemic schistosomiasis. Lancet 365: 1561-1569. (Pubitemid 40615405)
7. Gray DJ, McManus DP, Li Y, Williams GM, Bergquist R, Ross AG, 2010. Schistosomiasis elimination: lessons from the past guide the future. Lancet Infect Dis 10: 733-736.
8. World Health Organization, 2012. Meeting of the International Task Force for Disease Eradication, April 2012. Wkly Epidemiol Rec 87: 305-309.
9. Downs JA, Mguta C, Kaatano GM, Mitchell KB, Bang H, Simplice H, Kalluvya SE, Changlucha JM, Johnson WD Jr, Fitzgerald DW, 2011. Urogenital schistosomiasis in women of reproductive age in Tanzania's Lake Victoria region. Am J Trop Med Hyg 84: 362-369.
10. Da'dara AA, Harn DA, 2010. Elimination of helminth infection restores HIV-1c vaccine-specific T cell responses independent of helminth-induced IL-10. Vaccine 28: 1310-1317.
11. Savardekar LS, Balaiah D, Mali BN, 2010. Association of Schistosoma haematobium and human papillomavirus incervical cancer: a case report. Acta Cytol 54: 205-208.
12. Lyons B, Stothard R, Rollinson D, Khamis S, Simai KA, Hunter PR, 2009. A comparsion of urinary tract pathology and morbidity in adult populations from endemic and non-endmeic zones for urinary schistosomiasis on Unguja Island, Zanzibar. BMC Infect Dis 9: 189.
13. Kjetland EF, Leutsher PDC, Ndhlovu PD, 2012. A review of female genital schistosomiasis. Trends Parasitol 28: 58-65.
14. Richards FO, Eigege A, Miri ES, Jinadu MY, Hopkins DR, 2006. Integration of mass drug administration programmes in Nigeria: the challenge of schistosomiasis. Bull World Health Organ 84: 673-676. (Pubitemid 44338256)
15. Fatiregun AA, Osungbabe KO, Olumide AE, 2009. Cost-effectiveness of screening methods for urinary schistosomiasis in a school-based control programme in Ibadan, Nigeria. Health Policy 89: 72-77.
16. Kolaczinski JH, Hanson K, Robinson E, Picon D, Sabasio A, Mpakanteni M, Lado M, Moore S, Petty N, Brooker S, 2010. Integrated surveys of neglected tropical diseases in southern Sudan: how much do they cost and can they be refined? PLoS Negl Trop Dis 4: e745.
17. Guo J, Booth M, Jenkins J, Wang H, Tanner M, 1998. Field activity cost estimates for the first 3 years of the World Bank loan project for schistosomiasis control in China. Southeast Asian J Trop Med Pub Hlth 29: 706-713. (Pubitemid 128709177)
18. Wang L, Chen H, Guo J, Zeng X, Hong X, Xiong J, Wu X, Wang X, Wang L, Xia G, Hao Y, Chin D, Zhou X, 2009. A strategy to control transmission of Schistosoma japonicum in China. N Engl J Med 360: 121-128.
19. Salem S, Mitchell RI, El-Alim El-Dorey A, Smith JA, Barocas DA, 2011. Successful control of schistosomiasis and the changing epidemiology of bladder cancer in Egypt. BJU Int 107: 206-211.
20. World Health Organization, 2012. Schistosomiasis: population requiring preventive chemotherapy and number of people treated in 2010. Wkly Epidemiol Rec 27: 37-44.